Factors influencing mortality in intracranial infections caused by carbapenem-resistant Klebsiella Pneumoniae.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 Sep 2024
Historique:
received: 29 05 2024
accepted: 29 08 2024
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 5 9 2024
Statut: epublish

Résumé

It remains that intracranial infection has an alarming mortality and morbidity. Klebsiella pneumoniae (KP) have increasingly been isolated in ventriculitis and meningitis episodes. Intracranial infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) account for high mortality. To understand its clinical impact and related risk factors accurately are crucial in the management of bacterial intracranial infection. The retrospective study aimed to delineate the clinical risk of death from intracranial infection and analyze the risk factors. A total of 176 Klebsiella pneumoniae intracranial infectious patients were available to divide into CRKP group and carbapenem-susceptive Klebsiella Pneumoniae (CSKP) group. We performed survival analysis and estimate the time-varying effects of CRKP and CSKP infection on 30-day mortality. Infectious patients caused by CSKP was associated with lower mortality than CRKP group. The risk factors associated with death from intracranial infection caused by Klebsiella pneumoniae included SOFA scores, ventilator therapy, CRKP, and heart failure. Longer hospital stays are independently associated with lower mortality rates. Intracranial infection caused by CRKP was associated with excess mortality. Complex comorbidities mean higher mortality. Active supportive treatment is required for complicated patients with intracranial infections caused by carbapenem-resistant Klebsiella pneumoniae.

Identifiants

pubmed: 39237686
doi: 10.1038/s41598-024-71660-4
pii: 10.1038/s41598-024-71660-4
doi:

Substances chimiques

Carbapenems 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20670

Subventions

Organisme : Young and Middle-aged Scientific Technological Innovation Jie-Qing Talent Project
ID : YXKC2021042
Organisme : Henan Province Key Medical Science and Technology Research Project Co-established by Provincial and Ministerial Authorities (CN)
ID : SBGJ202102081
Organisme : Henan Province Science and Technology Research Project (CN)
ID : 242102311040
Organisme : Henan Province Natural Science Foundation Project (CN)
ID : 242300420384

Informations de copyright

© 2024. The Author(s).

Références

Carlson, R. D. et al. Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: A prospective cohort study. Metab. Brain Dis. 29(2), 269–279. https://doi.org/10.1007/s11011-013-9476-1 (2014).
doi: 10.1007/s11011-013-9476-1 pubmed: 24399496 pmcid: 4033836
Jacob, S. S. & Top, F. H. Friedländer bacillus meningitis; report of seven cases with two recoveries. Ann. Intern. Med. 28(5), 1003–1009. https://doi.org/10.7326/0003-4819-28-5-1003 (1948).
doi: 10.7326/0003-4819-28-5-1003 pubmed: 18858402
Tangden, T. & Giske, C. G. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: Clinical perspectives on detection, treatment and infection control. J. Intern. Med. 277, 501–512. https://doi.org/10.1111/joim.12342 (2015).
doi: 10.1111/joim.12342 pubmed: 25556628
Lu, C. H., Chang, W. N. & Chang, H. W. Klebsiella meningitis in adults: Clinical features, prognostic factors and therapeutic outcomes. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas. 9(5), 533–538. https://doi.org/10.1054/jocn.2001.1032.( (2002).
doi: 10.1054/jocn.2001.1032.(
Zhao, J. et al. Klebsiella pneumoniae-related brain abscess and meningitis in adults: Case report. Medicine 101(2), e28415. https://doi.org/10.1097/MD.0000000000028415 (2022).
doi: 10.1097/MD.0000000000028415 pubmed: 35029179 pmcid: 8757935
Bardak-Ozcem, S. & Sipahi, O. R. An updated approach to healthcare-associated meningitis. Expert Rev. Anti-infect. Ther. 12(3), 333–342. https://doi.org/10.1586/14787210.2014.890049 (2014).
doi: 10.1586/14787210.2014.890049 pubmed: 24512210
Tunkel, A. R. et al. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis*. Clin. Infect. Dis. 64, e34–e65. https://doi.org/10.1093/cid/ciw861 (2017).
doi: 10.1093/cid/ciw861 pubmed: 28203777 pmcid: 5848239
Pandey, S. et al. Clinical characteristics of hydrocephalus following the treatment of pyogenic ventriculitis caused by multi/extensive drug-resistant gram-negative Bacilli, Acinetobacter Baumannii, and Klebsiella Pneumoniae. Front. Surg. 9, 854627. https://doi.org/10.3389/fsurg.2022.854627 (2022).
doi: 10.3389/fsurg.2022.854627 pubmed: 35592123 pmcid: 9110772
Wang, H., Zhou, Q., Huang, K., Yang, X. & Wen, L. Intraventricular plus systemic antibiotic therapy for treating Polymyxin-resistant Klebsiella pneumoniae ventriculitis: A case report. Open Forum Infect. Dis. 9, ofac084. https://doi.org/10.1093/ofid/ofac084 (2022).
doi: 10.1093/ofid/ofac084 pubmed: 35355891 pmcid: 8962704
ValienteDeSantis, L. B. et al. Nosocomial meningitis caused by ESBL- and OXA-48-producing Klebsiella pneumoniae and treated with ceftazidime-avibactam. Report of one case and review of the literature. Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia 35, 572–576. https://doi.org/10.37201/req/043.2022 (2022).
doi: 10.37201/req/043.2022
Brook, I., Bricknell, K. S., Overturf, G. D. & Finegold, S. M. Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system. J. Infect. Dis. 137(4), 384–390. https://doi.org/10.1093/infdis/137.4.384 (1978).
doi: 10.1093/infdis/137.4.384 pubmed: 649985
Giske, C. G., Turnidge, J., Cantón, R., Kahlmeter, G., Committee. E. S. Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST). J. Clin. Microbiol. 60(3), e0027621. https://doi.org/10.1128/JCM.00276-21 (2022).
doi: 10.1128/JCM.00276-21 pubmed: 34346716
Bobenchik, A. M., Deak, E., Hindler, J. A., Charlton, C. L. & Humphries, R. M. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints. J. Clin. Microbiol. 53(3), 816–823. https://doi.org/10.1128/JCM.02697-14 (2015).
doi: 10.1128/JCM.02697-14 pubmed: 25540403 pmcid: 4390649
Yadegarynia, D. et al. Changing pattern of infectious agents in postneurosurgical meningitis. Casp. J. Intern. Med. 5(3), 170–175 (2014).
Tian, R., Hao, S., Hou, Z., Gao, Z. & Liu, B. The characteristics of post-neurosurgical bacterial meningitis in elective neurosurgery in 2012: A single institute study. Clin. Neurol. Neurosurg. 139, 41–45. https://doi.org/10.1016/j.clineuro.2015.09.002 (2015).
doi: 10.1016/j.clineuro.2015.09.002 pubmed: 26364156
Shi, Z. H. et al. Post-craniotomy intracranial infection in patients with brain tumors: A retrospective analysis of 5723 consecutive patients. Br. J. Neurosurg. 31(1), 5–9. https://doi.org/10.1080/02688697.2016.1253827 (2017).
doi: 10.1080/02688697.2016.1253827 pubmed: 27845572
Zhan, R. et al. Post-operative central nervous system infections after cranial surgery in China: Incidence, causative agents, and risk factors in 1,470 patients. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol. 33(5), 861–866. https://doi.org/10.1007/s10096-013-2026-2 (2014).
doi: 10.1007/s10096-013-2026-2
Nussinovitch, M. et al. Cerebrospinal fluid lactate dehydrogenase isoenzymes in children with bacterial and aseptic meningitis. Transl. Res. 154, 214–218. https://doi.org/10.1016/j.trsl.2009.06.011 (2009).
doi: 10.1016/j.trsl.2009.06.011 pubmed: 19766965
Shon, A. S., Bajwa, R. P. & Russo, T. A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed. Virulence 4(2), 107–118. https://doi.org/10.4161/viru.22718 (2013).
doi: 10.4161/viru.22718 pubmed: 23302790 pmcid: 3654609
Lee, H. L., Lee, H. C., Guo, H. R., Ko, W. C. & Chen, K. W. Clinical significance and mechanism of gas formation of pyogenic liver abscess due to Klebsiella pneumoniae. J. Clin. Microbiol. 42(6), 2783–2785. https://doi.org/10.1128/JCM.42.6.2783-2785.2004 (2004).
doi: 10.1128/JCM.42.6.2783-2785.2004 pubmed: 15184470 pmcid: 427832
Hsieh, D. Y. et al. Sex-based differences in bacterial meningitis in adults: Epidemiology, clinical features, and therapeutic outcomes. J. Infect. Public Health 14(9), 1218–1225. https://doi.org/10.1016/j.jiph.2021.08.018 (2021).
doi: 10.1016/j.jiph.2021.08.018 pubmed: 34438332
Li, Y. et al. Convergence of carbapenem resistance and hypervirulence leads to high mortality in patients with postoperative Klebsiella pneumoniae meningitis. J. Glob. Antimicrob. Resist. 27, 95–100. https://doi.org/10.1016/j.jgar.2021.02.035( (2021).
doi: 10.1016/j.jgar.2021.02.035( pubmed: 34133987
Kastenbauer, S. & Pfister, H. W. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126(Pt 5), 1015–1025. https://doi.org/10.1093/brain/awg113 (2003).
doi: 10.1093/brain/awg113 pubmed: 12690042
Han, J. H. et al. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 64(7), 839–844. https://doi.org/10.1093/cid/ciw856 (2017).
doi: 10.1093/cid/ciw856
Fang, C. T. et al. Klebsiella pneumoniae genotype K1: An emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 45(3), 284–293. https://doi.org/10.1086/519262 (2007).
doi: 10.1086/519262

Auteurs

Chengcheng Lai (C)

Department of General Practice, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Zijun Ma (Z)

Department of General Practice, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Yonggang Luo (Y)

Department of Neurosurgical Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Luoyg_514@126.com.

Yuan Gao (Y)

Department of Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.

Zhuanghao Wu (Z)

Department of Neurosurgical Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Jun Zhang (J)

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450002, China.

Weiwei Xu (W)

Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH